<DOC>
	<DOC>NCT01102660</DOC>
	<brief_summary>PH-797804 is a potent inhibitor of inflammatory mediators that have a potential role in pain signalling following nerve injury and inflammation. Blocking such mediators may potentially have a therapeutic benefit by reducing pain.</brief_summary>
	<brief_title>Clinical Trial to Examine the Pain Relief of PH-797804 Alone Or With Naproxen in Subjects With Osteoarthritis of the Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Male or female subjects between, and including, the ages of 18 and 75 years. Females must be of nonchildbearing potential. Diagnosis of osteoarthritis of the knee based on American College of Rheumatology criteria with Xray confirmation (a KellgrenLawrence Xray grade of â‰¥2. History of diseases other than osteoarthritis that may involve the index knee. Other severe pain that impairs the assessment of osteoarthritis of pain. Electrocardiogram abnormalities. History of gastrointestinal disorders.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Knee osteoarthritis</keyword>
	<keyword>clinical trial</keyword>
	<keyword>cross-over</keyword>
</DOC>